Abstract
OBJECTIVE: Obesity, defined as a body mass index (BMI) greater than 30 kg/m2, is now recognised as a risk factor for diabetes mellitus, hyperlipidaemia, colon cancer, sudden death and other cardiovascular diseases. In this study, it is hypothesized that obesity is an independent risk factor for lipid peroxidation and decreased activities of cytoprotective enzymes in humans.
SUBJECTS: Fifty normal healthy subjects with healthy BMI (19–25 kg/m2) and 250 subjects with different grades of obesity (30–50 kg/m2) with no history of smoking or biochemical evidence of diabetes mellitus, hypertension, hyperlipidaemia, renal or liver disease or cancer.
MEASUREMENTS: To test this hypothesis, we assessed lipid peroxidation and cytoprotection by measuring the concentrations of plasma malondialdehyde (P-MDA) and the activities of erythrocyte copper zinc-superoxide dismutase (CuZn-SOD) and glutathione peroxidase (GPX).
RESULTS: The concentration of P-MDA was significantly lower (P<0.001) in subjects with healthy BMI (2.53±0.04 µmol/l) than in those with BMI above 40 kg/m2 (4.75+0.05 µmol/l). Furthermore, there was a significantly positive association (r=0.342, P=0.013) between BMI and P-MDA. On the other hand, subjects with healthy BMI had significantly higher (P<0.001) erythrocyte CUZn-SOD (1464±23 units/g Hb) and GPX (98.4±3.3 units/g Hb) than those with BMI above 40 kg/m2 (1005±26 units/g Hb) and (84.3±6.7 units/g Hb) respectively. Furthermore, erythrocyte CuZn-SOD and GPX activities were negatively associated with BMI (r=−0.566, P=0.005 and r=−0.436, P=0.018) respectively.
CONCLUSION: It is concluded from these results that obesity in the absence of smoking, diabetes mellitus, hyperlipidaemia, renal or liver disease causes lipid peroxidation and decreased activities of cytoprotective enzymes, and should therefore receive the same attention as obesity with complications.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
US Department of Health and Human Services. The Surgeon General's Report on Nutrition and Health US Department of Health and Human Services: Washington, DC 1988 Department of Health and Human Services Publication 88-50210
Manson JE, Stampfer MJ, Hennekens CH, Willet WC . Body weight and longevity. A reassessment JAMA 1987 257: 353–358.
Westlund K, Nicolaysen R . Ten—year mortality and morbidity related to serum cholesterol Scand J Clin Lab Invest 1972 (Suppl): 30: 1–24.
Borhain NO, Hechter HH, Breslow L . Report of a ten-year follow up of the San Francisis longshore Men J Chron Dis 1963 16: 1251–1266.
Bray GA . Pathophysiology of obesity Am J Clin Nutr 1992 55: 4885–4945.
Stuart RB . Behavioral control of overeating Behav Res Ther 1967 5: 357–365.
Glueck CJ, Taylor HL, Jacobs D, Morrison JA, Beaglehole R, Williams OD . Plasma high density lipoprotein cholesterol: association with measurements of body mass: the Lipid Research Clinics Program Prevalence Study Circulation 1980 62 (Suppl IV): IV.62–IV.69.
Hall JE, Louis K . Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity Hypertension 1994 23: 381–394.
Domfeld LP, Maxwell MH, Waks A, Tuck M . Mechanisms of hypertension in obesity Kidney Int Suppl 1987 22: 5254–5288.
Hirose H, Saito I, Tsujioka M, Mori M, Kawabe H, Saruta T . The obese gene product, leptin: possible role in obesity-related hypertension in adolescents J Hypertens 1998 16: 2007–2012.
Kopelham PG, Noonan K, Goulton R, Forest AJ . Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity Clin Endocrinol (Oxf) 1985 23: 87–94.
Tuck ML . Obesity, the sympathetic nervous system, and essential hypertension Hypertension 1992 19 (Suppl): 1-67–1-77.
Vincent HK, Powers SK, Stewart DJ, Shanely RA, Demirel H, Nalto H . Obesity is associated with increased myocardial oxidative stress Int J Obes Relat Metab Disord 1999 23: 67–74.
Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJ . Development of hypertension in a rat model of diet-induced obesity Hypertension 2000 35: 1009–1015.
Yagi K . Simple fluorometric assay for lipoperoxide in blood plasma Biochem Res 1976 15: 212–216.
National Committee for Clinical Laboratory Standards. Reference and selected procedures for the quantitative determination of haemoglobin in blood 2nd edn. Approved Standard NCCLS document H15-A2, Vol 4, no 3 NCCLS: Villanova, PA 1994.
McCord JM, Fridovich I . Superoxide dismutase. An enzymatic function for erythrocuprein (hemocuprein) J Biol Chem 1969 244: 6049–6055.
Paglia DE, Valentine WN . Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase J Lab Clin Med 1967 70: 158–169.
Steinberg D . A critical look at the evidence for the oxidation of LDL in atherogenesis Atherosclerosis 1997 13 (Suppl): 5–7.
Cerutti PA . Oxy-radicals and cancer Lancet 1994 344: 796–798.
Sagar S, Kallo IJ, Kaul N, Ganguly NK, Sharma BK . Oxygen free radicals in essential hypertension Mol Cell Biochem 1992 111: 103–108.
Russo C, Oliviri O, Girelli D, Faccini G, Zenari ML, Lombardi S, Corrocher R . Anti-oxidant status and lipid peroxidation in patients with essential hypertension J Hypertens 1998 16: 1267–1271.
Turrens JF . Superoxide production by the mitochondrial respiratory chain Biosci Rep 1997 17: 3–8.
Lechieitner M, Koch T, Harold M, Dzien A, Hoppiahler F . Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors J Intern Med 2000 248: 67–76.
Moor de Burgos A, Wartanowics M, Ziemlanski S . Blood vitamin and lipid levels in overweight and obese women Eur J Clin Nutr 1992 46: 803–808.
Kuno T, Hozumi M, Morinobu TM, Mingei Z, Tamai H . Antioxidant vitamin levels in plasma and low density lipoprotein of obese girls Free Radic Res 1998 28: 81–86.
Decsi T, Molnar D, Koletzko B . Reduced plasma concentrations of alpha-tocopherol and beta-carotene in obese boys J Paediatr 1997 130: 653–655.
Strauss RS . Comparison of serum concentrations of α-tocopherol and β-carotene in a cross sectional sample of obese and non-obese children (NHANES III) J Paediatr 1999 134: 160–165.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Olusi, S. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes 26, 1159–1164 (2002). https://doi.org/10.1038/sj.ijo.0802066
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802066
Keywords
This article is cited by
-
Association Between Dietary Intake After Roux-en-Y Gastric Bypass Surgery and Antioxidant/inflammatory Status: A 6-Month Pilot Prospective Cohort Study
Obesity Surgery (2024)
-
Relationship Between Markers of Chronic Inflammation and Copper Nutritional Status in Obese Women
Biological Trace Element Research (2023)
-
Impact of Nickel Oxide Nanoparticles (NiO) on Oxidative Stress Biomarkers and Hemocyte Counts of Mytilus galloprovincialis
Biological Trace Element Research (2022)
-
Feeling the pressure: (patho) physiological mechanisms of weight gain and weight loss in humans
Hypertension Research (2017)
-
Race/ethnicity determines the relationships between oxidative stress markers and blood pressure in individuals with high cardiovascular disease risk
Journal of Human Hypertension (2017)